Current status and future prospects of nanotechnology in cosmetics

被引:137
|
作者
Mihranyan, Albert [1 ]
Ferraz, Natalia [1 ]
Stromme, Maria [1 ]
机构
[1] Uppsala Univ, Dept Engn Sci, S-75121 Uppsala, Sweden
基金
瑞典研究理事会;
关键词
SOLID LIPID NANOPARTICLES; HEALTH-RISK ASSESSMENT; HESPERETIN NANOSUSPENSIONS; EVAPORATIVE PRECIPITATION; GOLD NANOPARTICLES; ENHANCED DELIVERY; PARTICLE-SIZE; AMINO-ACID; IN-VITRO; SKIN;
D O I
10.1016/j.pmatsci.2011.10.001
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The cosmetics industry was among the first to implement nanotechnological principles in product development. Of more than one thousand registered nanotechnology-based products on the global market in 2009, more than 13% were classified as products for cosmetic use. In this review we highlight the most important scientific articles, expert opinions by regulatory authorities, and patent literature from Europe and the USA for the time period between 2000 and 2010 concerning the use of nanotechnology in dermatological, dental, and haircare products intended for improving the appearance of the user. We present current and suggested uses of nanotechnology in cosmetics with the main focus on nanomaterials as active substances, carriers and formulation aids. The new functionalities these materials are claimed to introduce are also described. We briefly discuss public opinion of nanotechnology in general, and include the most important definitions related to this emerging technology along with a summary of the general characteristics of nanoparticles and their safety aspects. The aim of the review is, thus, to provide an update on the current status and trends of research and industrial development related to the use of nanotechnology in cosmetics and to give an indication of where the field could be heading in the future. (C) 2011 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:875 / 910
页数:36
相关论文
共 50 条
  • [21] SASSYER: Current status and future prospects
    Beausang, CW
    PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE FISSION AND PROPERTIES OF NEUTRON-RICH NUCLEI, 2003, : 597 - 603
  • [22] CURRENT STATUS AND FUTURE PROSPECTS FOR TUBERCULOSIS
    Rawal, Shruti
    Sood, Richa
    Mahajan, Nipun
    Sharma, Manju
    Sharma, Ajay
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (05): : 128 - 134
  • [23] Clofazimine: current status and future prospects
    Cholo, Moloko C.
    Steel, Helen C.
    Fourie, P. B.
    Germishuizen, Willem A.
    Anderson, Ronald
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (02) : 290 - 298
  • [24] Burosumab: Current status and future prospects
    Goyal, Alpesh
    Tandon, Nikhil
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 38 (02)
  • [25] CURRENT STATUS AND FUTURE PROSPECTS OF NOTES
    不详
    DIGESTIVE ENDOSCOPY, 2010, 22 (04) : A23 - A75
  • [26] Urinalysis: Current status and prospects for the future
    Lorincz, AE
    Kelly, DR
    Dobbins, GC
    Cardone, VS
    Fuchs, SA
    Schilleci, JL
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1999, 29 (03): : 169 - 175
  • [27] Pneumoconiosis: current status and future prospects
    Qi, Xian-Mei
    Luo, Ya
    Song, Mei-Yue
    Liu, Ying
    Shu, Ting
    Pang, Jun-Ling
    Wang, Jing
    Wang, Chen
    CHINESE MEDICAL JOURNAL, 2021, 134 (08) : 898 - 907
  • [28] Gastroenterology, current status and prospects for the future
    Ivashkin, VT
    Komarov, FI
    TERAPEVTICHESKII ARKHIV, 2002, 74 (02): : 5 - 8
  • [29] RADIODIAGNOSIS - CURRENT STATUS AND PROSPECTS FOR THE FUTURE
    ROZENSHTRAUKH, LS
    KLINICHESKAYA MEDITSINA, 1987, 65 (11): : 78 - 84
  • [30] INTERSPUTNIK: Current status and future prospects
    Bakmann, N
    Borovkov, V
    Rodriguez, O
    2ND INTERNATIONAL CONFERENCE ON SATELLITE COMMUNICATIONS - PROCEEDINGS OF ICSC '96, VOLS 1-4, 1996, : 21 - 23